Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:monoclonal_antibody
|
| gptkbp:bfsLayer |
6
|
| gptkbp:bfsParent |
gptkb:bamlanivimab
|
| gptkbp:activities |
neutralizes virus
|
| gptkbp:approves |
gptkb:drug
|
| gptkbp:can_be_used_with |
gptkb:bamlanivimab
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:developed_by |
gptkb:Eli_Lilly_and_Company
|
| https://www.w3.org/2000/01/rdf-schema#label |
etesevimab
|
| gptkbp:manager |
intravenous
|
| gptkbp:marketed_as |
gptkb:Etesevimab
|
| gptkbp:regulatory_compliance |
Emergency Use Authorization
|
| gptkbp:targets |
gptkb:SARS-Co_V-2
|